Wolverine Trading’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-34,500
Closed -$450K 6661
2021
Q3
$450K Buy
+34,500
New +$460K ﹤0.01% 4094
2018
Q3
Sell
-93,000
Closed -$608K 5698
2018
Q2
$608K Hold
93,000
﹤0.01% 2824
2018
Q1
$608K Buy
+93,000
New +$652K ﹤0.01% 2824
2017
Q3
Sell
-41,500
Closed -$341K 4902
2017
Q2
$341K Buy
41,500
+13,000
+46% +$106K ﹤0.01% 2855
2017
Q1
$232K Buy
+28,500
New +$246K ﹤0.01% 3343

Other funds holding RDY

Wolverine Trading's RDY Position: Q4 2021 in Review

Wolverine Trading sold out of Dr. Reddy's Laboratories (RDY) in Q4 2021, closing a stake of 15,450 shares — an estimated $201K sold.

Wolverine Trading first reported a position in RDY in Q2 2017 and held it in 4 quarters. The position peaked at $320K in Q2 2018. 147 funds tracked by Wall St. Rank hold RDY as of Q4 2021.

  • Wolverine Trading reported no remaining Dr. Reddy's Laboratories position as of Q4 2021 after selling out during the quarter.
  • Wolverine Trading sold 15,450 Dr. Reddy's Laboratories shares in Q4 2021, an estimated $201K.
  • Wolverine Trading first reported a position in Dr. Reddy's Laboratories in Q2 2017 and held it in 4 quarters.
  • Wolverine Trading's Dr. Reddy's Laboratories position peaked at $320K in Q2 2018.
  • 147 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2021.

Based on Wolverine Trading's 13F filing for Q4 2021, filed 14 Feb 2022.